-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to Yahoo Finance and Insider Monkey, the market value of the biotech industry will grow rapidly and is expected to reach $950 billion by 2027
1.
1.
2.
2.
3.
3.
4.
4.
5.
5.
6.
6.
7.
7.
8.
8.
Regeneron: $8.
58 billion
Headquartered in New York, Regeneron develops medicines for infectious diseases, eye diseases, cardiovascular, allergic and inflammatory diseases, and cancer
.
The company reported net income of $8.
58 billion in 2021, bringing its full-year revenue to $16.
07 billion
.
Of this, as much as $6.
19 billion comes from Regen-Cov, a combination therapy of COVID-19 antibodies developed by it
.
In 2021, the U.
S.
FDA granted emergency authorization to REGEN-COV for the treatment of high-risk individuals with recently diagnosed mild to moderate COVID-19
.
Reference source: BioSpace Looks at the Top 8 Biopharma Companies by Net Income
Reference source: BioSpace Looks at the Top 8 Biopharma Companies by Net Income